DICE Therapeutics, Inc. (DICE): Price and Financial Metrics
DICE Price/Volume Stats
Current price | $47.55 | 52-week high | $47.90 |
Prev. close | $47.52 | 52-week low | $15.08 |
Day low | $47.46 | Volume | 4,332,900 |
Day high | $47.83 | Avg. volume | 1,028,719 |
50-day MA | $42.55 | Dividend yield | N/A |
200-day MA | $34.31 | Market Cap | 2.27B |
DICE Stock Price Chart Interactive Chart >
DICE Therapeutics, Inc. (DICE) Company Bio
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is S011806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4Ã7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVÃ1/aVÃ6 integrin for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
DICE Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | 40.14% |
5-year | N/A |
YTD | N/A |
2023 | 0.00% |
2022 | 23.27% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...